The Top Six Ways Trump’s Policies Will Impact Pharmacies
We're still within the first 100 days of a new administration. What is happening, and what can you expect?
2. Lower drug prices
Pharmaceutical manufacturers have been under fire for their high drug prices for at least the last two years, and President Trump has been one of the biggest critics on high prices—particularly for Medicare beneficiaries. He recently said that drugmakers are “getting away with murder” in terms of drug pricing.
“For Medicare, for Medicaid, we have to get prices way down, so that’s what we’re going to be talking about. We’re also going to be streamlining the process so that from your standpoint so that when you have a drug you can actually get it approved—if it works—instead of waiting for many, many years,” Trump said at a late January meeting with pharmaceutical manufacturers, including Merck and Johnson & Johnson, CNN reported.
“President Donald J. Trump has spoken out many occasions about his concerns with regard to this issue during his presidential campaign and since his Inauguration,” Hoey said. “While specific proposals have not been unveiled, the president has spoken favorably about Medicare Part D possibly being able to negotiate lower prescription drug prices and about the possible reimportation of drugs from Canada.”